Matches in SemOpenAlex for { <https://semopenalex.org/work/W3158589516> ?p ?o ?g. }
- W3158589516 abstract "Abstract Active‐targeting nanomedicine formulations have an intricate in vivo behavior. Nanomedicines developed to target endothelial α v β 3 ‐integrin are recently demonstrated to display extensive uptake by circulating phagocytes. These phagocytes show inherent tumor‐homing capacities and therefore are capable of actively delivering the endocytosed nanomaterial in lesions. Here, the targeting kinetics and mechanisms of cyclic arginine–glycine–aspartate (cRGD)‐decorated lipid nanoparticles (NPs) toward activated vasculature in inflamed lesions during wound healing are studied. The cRGD‐NP targeting toward inflamed lesions is identified to be mechanistically similar to the NP accumulation in cancerous lesions. Through a complementary experimental approach, it is observed that circulating phagocytes engage cRGD‐NPs and are subsequently homed to the inflamed endothelium. The inflammation‐associated phagocytes remain static among endothelial cells upon targeting, resulting in the extensive presence of cRGD‐NP‐positive phagocytes in the angiogenic vessels. Hence, phagocytic immune cells contribute to cRGD‐NP targeting toward angiogenesis. This mechanistic study underlines the need for detailed investigations of NP in vivo behavior. This is critically important for the realization of NPs potential as advanced (immunological) therapeutic agents." @default.
- W3158589516 created "2021-05-10" @default.
- W3158589516 creator A5007050875 @default.
- W3158589516 creator A5008616618 @default.
- W3158589516 creator A5014426023 @default.
- W3158589516 creator A5032887845 @default.
- W3158589516 creator A5060607001 @default.
- W3158589516 creator A5073836649 @default.
- W3158589516 creator A5073971956 @default.
- W3158589516 creator A5079522186 @default.
- W3158589516 creator A5082333101 @default.
- W3158589516 creator A5088098979 @default.
- W3158589516 date "2021-05-03" @default.
- W3158589516 modified "2023-10-16" @default.
- W3158589516 title "Cyclic Arginine–Glycine–Aspartate‐Decorated Lipid Nanoparticle Targeting toward Inflammatory Lesions Involves Hitchhiking with Phagocytes" @default.
- W3158589516 cites W1597347415 @default.
- W3158589516 cites W1871753595 @default.
- W3158589516 cites W1874889006 @default.
- W3158589516 cites W1949832432 @default.
- W3158589516 cites W1967990189 @default.
- W3158589516 cites W1970197294 @default.
- W3158589516 cites W1970596902 @default.
- W3158589516 cites W1974960284 @default.
- W3158589516 cites W1985130894 @default.
- W3158589516 cites W2012860078 @default.
- W3158589516 cites W2019583561 @default.
- W3158589516 cites W2028543411 @default.
- W3158589516 cites W2030160629 @default.
- W3158589516 cites W2042949277 @default.
- W3158589516 cites W2046768800 @default.
- W3158589516 cites W2070550441 @default.
- W3158589516 cites W2100588727 @default.
- W3158589516 cites W2115728092 @default.
- W3158589516 cites W2156610002 @default.
- W3158589516 cites W2163105501 @default.
- W3158589516 cites W2169111202 @default.
- W3158589516 cites W2279217276 @default.
- W3158589516 cites W2297473952 @default.
- W3158589516 cites W2303714942 @default.
- W3158589516 cites W2305279678 @default.
- W3158589516 cites W2342130560 @default.
- W3158589516 cites W2546434191 @default.
- W3158589516 cites W2727515347 @default.
- W3158589516 cites W2746083900 @default.
- W3158589516 cites W2768778626 @default.
- W3158589516 cites W2789720473 @default.
- W3158589516 cites W2791311190 @default.
- W3158589516 cites W2792366526 @default.
- W3158589516 cites W2804669050 @default.
- W3158589516 cites W2805172281 @default.
- W3158589516 cites W2891621105 @default.
- W3158589516 cites W2896042631 @default.
- W3158589516 cites W2896491161 @default.
- W3158589516 cites W2897535855 @default.
- W3158589516 cites W2899377742 @default.
- W3158589516 cites W2899726004 @default.
- W3158589516 cites W2962134339 @default.
- W3158589516 cites W2965302019 @default.
- W3158589516 cites W2969488042 @default.
- W3158589516 cites W2981372428 @default.
- W3158589516 cites W2998882776 @default.
- W3158589516 cites W3004179479 @default.
- W3158589516 cites W3016492545 @default.
- W3158589516 cites W3021413923 @default.
- W3158589516 cites W3024377028 @default.
- W3158589516 cites W3045886659 @default.
- W3158589516 cites W3046387576 @default.
- W3158589516 cites W3090431781 @default.
- W3158589516 cites W3113034789 @default.
- W3158589516 cites W3131224233 @default.
- W3158589516 doi "https://doi.org/10.1002/advs.202100370" @default.
- W3158589516 hasPublicationYear "2021" @default.
- W3158589516 type Work @default.
- W3158589516 sameAs 3158589516 @default.
- W3158589516 citedByCount "9" @default.
- W3158589516 countsByYear W31585895162021 @default.
- W3158589516 countsByYear W31585895162022 @default.
- W3158589516 countsByYear W31585895162023 @default.
- W3158589516 crossrefType "journal-article" @default.
- W3158589516 hasAuthorship W3158589516A5007050875 @default.
- W3158589516 hasAuthorship W3158589516A5008616618 @default.
- W3158589516 hasAuthorship W3158589516A5014426023 @default.
- W3158589516 hasAuthorship W3158589516A5032887845 @default.
- W3158589516 hasAuthorship W3158589516A5060607001 @default.
- W3158589516 hasAuthorship W3158589516A5073836649 @default.
- W3158589516 hasAuthorship W3158589516A5073971956 @default.
- W3158589516 hasAuthorship W3158589516A5079522186 @default.
- W3158589516 hasAuthorship W3158589516A5082333101 @default.
- W3158589516 hasAuthorship W3158589516A5088098979 @default.
- W3158589516 hasConcept C134018914 @default.
- W3158589516 hasConcept C150903083 @default.
- W3158589516 hasConcept C160448771 @default.
- W3158589516 hasConcept C170493617 @default.
- W3158589516 hasConcept C185592680 @default.
- W3158589516 hasConcept C195687474 @default.
- W3158589516 hasConcept C203014093 @default.
- W3158589516 hasConcept C207001950 @default.
- W3158589516 hasConcept C2776914184 @default.
- W3158589516 hasConcept C2776992346 @default.
- W3158589516 hasConcept C2780394083 @default.